Post-mortem diagnosis: evolving a team approach
The decline in autopsy rates in the past four decades in developed countries (to less than 5% in the USA1) has paralleled continued discrepancies between clinical and autopsy diagnoses of up to 20-30%.2,3 The interconnected causes of low autopsy rates include absence of predictable funding, clinical...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2013-07, Vol.382 (9888), p.186-188 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The decline in autopsy rates in the past four decades in developed countries (to less than 5% in the USA1) has paralleled continued discrepancies between clinical and autopsy diagnoses of up to 20-30%.2,3 The interconnected causes of low autopsy rates include absence of predictable funding, clinical overconfidence in diagnostic modalities, reluctance to request and undertake autopsies, decreased expertise in autopsy, a scarcity of auditable standards and mandated autopsy rates, and reluctance of families to consent to autopsy.1,4 The need for mortality data based on accurate post-mortem diagnosis of disease and identification of cause of death has increased interest in minimally or less-invasive procedures to replace or augment conventional autopsy.5 However, uncertainty about the accuracy of less-invasive diagnostic techniques for post mortems and about integration with conventional autopsy has raised concerns about whether reliable population-based determination of cause of death can be maintained. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(13)60890-9 |